Clinical Trial Update: Efficacy and Safety of Levemir® Used as Basal Insulin

View source ↗

Summary

This update reports the efficacy and safety results of using Levemir (insulin detemir) as basal insulin in people with diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus
• Type 2 Diabetes Mellitus

Drugs mentioned

• Levemir (insulin detemir)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Status: COMPLETED